Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Diabetes Care 2006;29(11):2365-2370
Stepping-Stones Towards Triple Agonism: A Summary of GLP-1/GIP and GLP-1/GCG Dual-Agonist Development The development of triple agonists for obesity has built upon successes of several dual combinations of entero-pancreatic hormone receptor agonists, in particular, GLP-1/GIP dual agonists and GLP-1/GCG dual agonists
Drawing and Administering the Injection Step 1: Remove the vial from the refrigerator and allow it to reach room temperature for a few minutes
Mechanisms of action of the US Food and Drug Administration-approved antisense oligonucleotide drugs
CDSCO has recently issued an advisory on the promotion of prescription medicines indicated for obesity and metabolic disorders
For longer-term storage, freezer conditions are generally preferred for many lyophilized research materials
US$ 28.66
US$ 20.13
US$ 29.84
US$ 29.48
